Zegerid Approval History
- FDA approved: Yes (First approved June 15th, 2004)
- Brand name: Zegerid
- Generic name: omeprazole and sodium bicarbonate
- Previous name: Rapinex
- Company: Santarus, Inc.
- Treatment for: Duodenal Ulcer, GERD, Stomach Ulcer, Erosive Esophagitis
Zegerid (omeprazole and sodium bicarbonate) is proton-pump inhibitor and antacid combination for the treatment of duodenal ulcer, heartburn and other symptoms associated with gastroesophageal reflux disease (GERD), and erosive esophagitis.
Development History and FDA Approval Process for Zegerid
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.